Market Overview and Dow’s Performance

At 10:41 AM Central Europe on Friday, 23 April 2026, the Dow Jones Industrial Average (DOW) advanced by 4.71 % over the preceding 24 hours. The index’s climb reflects a broader uptick in investor confidence, driven in part by encouraging corporate earnings reports and positive macro‑economic data.

On the same day, a single share of Dow Inc. traded at USD 31.81 on major exchanges. The company’s market capitalization currently stands at USD 21.9 billion, and the trading volume over the past day totaled approximately USD 363 million. Relative to the close of the prior month, Dow’s share price has risen by 11.03 %, signalling sustained momentum for the chemical‑manufacturing giant.

Key technical indicators underline this trend. The 200‑day simple moving average sits at USD 32.40, suggesting that the current price level remains below long‑term averages but above short‑term fluctuations. Historically, Dow’s 52‑week high reached USD 42.74 on 31 March 2026, while the 52‑week low dipped to USD 20.93 on 20 November 2025. These figures illustrate the index’s volatility but also its potential for further gains as it approaches the upper quartile of its recent range.

F (FFIV)

  • Change: Down 1.86 %
  • Price: USD 450.08
  • Market Cap: USD 26 billion
  • P/E Ratio: 36.53

Ulta Beauty (ULTA)

  • Change: Up 4.62 %
  • Price: USD 635.01
  • Market Cap: USD 26 billion
  • P/E Ratio: 22.11
  • Historical Context: A $100 investment in October 2023, when the share hovered near USD 371.85, would have yielded a fraction of a share. By the close of trading on 21 October 2026, the price had risen to approximately USD 607, demonstrating significant appreciation for long‑term shareholders.

Casey’s General Stores (CASY)

  • Change: Up 2.66 %
  • Price: USD 713.65
  • Market Cap: USD 25.7 billion
  • P/E Ratio: 33.47

Labcorp (LH)

  • Change: Up 1.91 %
  • Price: USD 329.93
  • Market Cap: USD 26.3 billion
  • P/E Ratio: 26.77
  • Strategic Moves: Labcorp announced a partnership with the U.S. Food and Drug Administration and Charles River Laboratories to improve drug‑abuse risk assessment tools. It also plans to acquire laboratory testing businesses from BioReference Health, expanding its clinical and women’s health services portfolio.

Fiserv (FISV)

  • Change: Up 5.41 %
  • Price: USD 50.82
  • Market Cap: USD 25.6 billion
  • P/E Ratio: 9.25

About Dow Inc.

Dow Inc. is a leading U.S. chemical company with a global footprint. Its product portfolio spans liquid injection molding, architectural fabrication, leather, textiles, automotive, rubber consumer goods, and food‑industry applications. The firm supplies a diverse range of customers across multiple sectors, leveraging advanced manufacturing technologies and sustainability initiatives. Dow is listed on the New York Stock Exchange and maintains a robust research and development pipeline aimed at delivering innovative solutions to its worldwide clientele. For more information, visit www.dow.com .